360biolabs’ analytical programs satisfy global regulatory requirement and ensure the success of your program. We offer both readily available and custom developed assays validated to international guidelines. Whether it be small molecule, biologic innovator or biosimilar, establishing the pharmacokinetic profile is key to progressing your candidate drug.
Our ever expanding state-of-the-art instruments support high throughput and high sensitivity quantitative analysis by LC-MS/MS to low nanogram and picogram per millilitre detection levels from a wide variety of biological matrices. Our bioanalytical chemistry team also conduct metabolite and biomarker identification and analysis.
Our immunology team has several decades of experience in the development, verification and validation of ELISA and high-performance electrochemiluminescence immunoassay (MSD®) assays for the detection of biologic therapies.